Sarcomatoid tumors show fewer CD4+ and CD8+ T cells in the tumor and are characterized by a loss of Th1 features such as T-bet (marker for Th1 polarization) and granzyme B expression, which are required for an efficacious anti-tumor immune response. The gene discussed is CD4; the disease is neoplasm.